Topics

About 85% of all lung cancer cases are diagnosed as non-small cell lung cancer (#NSCLC), many caused by genetic mutations in the cells of our bodies – like the epidermal growth factor receptor (EGFR). #LCSMpic.twitter.com/dbsXT4YCZ5

07:19 EDT 15 Aug 2019 | AztraZeneca

About 85% of all lung cancer cases are diagnosed as non-small cell lung cancer ( ), many caused by genetic mutations in the cells of our bodies – like the epidermal growth factor receptor (EGFR).

Original Article: About 85% of all lung cancer cases are diagnosed as non-small cell lung cancer (#NSCLC), many caused by genetic mutations in the cells of our bodies – like the epidermal growth factor receptor (EGFR). #LCSMpic.twitter.com/dbsXT4YCZ5

NEXT ARTICLE

More From BioPortfolio on "About 85% of all lung cancer cases are diagnosed as non-small cell lung cancer (#NSCLC), many caused by genetic mutations in the cells of our bodies – like the epidermal growth factor receptor (EGFR). #LCSMpic.twitter.com/dbsXT4YCZ5"

Quick Search

Relevant Topics

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...